Results 111 to 120 of about 2,347,326 (232)

Identification of a novel BET bromodomain inhibitor-sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers.: CYCLON-induced Rituximab resistance [PDF]

, 2013
International audienceImmuno-chemotherapy elicit high response rates in B-cell non-Hodgkin lymphoma but heterogeneity in response duration is observed, with some patients achieving cure and others showing refractory disease or relapse.
Alexandra Debernardi, Anouk Emadali, Benoit Bernay, Carlo Petosa, Charles E. McKenna, Christophe Bruley, Claire Rome, Dominique Leroux, Elena Ferri, Florence Combes, Friedberg JW, Juliana Bruder‐Costa, Jérôme Garin, Kato M, Mary B. Callanan, Myriam Ferro, Patricia Betton, Rousseaux S, Rémy Gressin, Saadi Khochbin, Samuel Duley, Sieme Hamaidia, Sophie Rousseaux, Swerdlow SH, Sylvie Kieffer‐Jaquinod   +24 more
core   +4 more sources

The mTORC1 inhibitor everolimus prevents and treats Eμ-Myc lymphoma by restoring oncogene-induced senescence [PDF]

, 2013
MYC deregulation is common in human cancer. IG-MYC translocations that are modeled in EμMyc mice occur in almost all cases of Burkitt lymphoma as well as in other B-cell lymphoproliferative disorders.
Astle, Megan V., Bots, Michael, Bywater, Megan J., Chan, Christopher J., Hannan, Katherine M., Hannan, Ross D., Johnstone, Ricky W., Kinross, Kathryn M., Lindemann, Ralph K., Lowe, Scott W., McArthur, Grant A., Pearson, Richard B., Poortinga, Gretchen, Shortt, Jake, Smyth, Mark J., Stanley, Kym L., Waldeck, Kelly, Wall, Meaghan   +17 more
core   +1 more source

Aryl Hydrocarbon Receptor Interacting Protein Maintains Germinal Center B Cells through Suppression of BCL6 Degradation [PDF]

, 2019
B cell lymphoma-6 (BCL6) is highly expressed in germinal center B cells, but how its expression is maintained is still not completely clear. Aryl hydrocarbon receptor interacting protein (AIP) is a cochaperone of heat shock protein 90. Deletion of Aip in
Allen, Baron, Basso, Bedekovics, Boulianne, Bunting, Caimari, Calado, Capasso, Cerami, Cerchietti, Culjkovic-Kraljacic, Dent, Dominguez-Sola, Duan, Duy, García de Vinuesa, Hernández-Ramírez, Hertlein, Huang, Hussain, Kazlauskas, Komander, Kriegenburg, Kutner, Lee, Lees, Leontiou, Li, Manjarrez, Mesin, Meyer, Morales, Niu, Paul, Perrody, Phan, Polier, Sander, Sato, Schneider, Schopf, Stockinger, Taipale, Taipale, Trepel, Trivellin, Vaidyanathan, Veldhoen, Victora, Victora, Vierimaa, Villa, Weigert, Whitesell, Ye, Zong   +56 more
core   +4 more sources

Determination of B-cell clonality in Hodgkin’s lymphoma

Клиническая онкогематология, 2014
B-cell origin of Hodgkin’s lymphoma was demonstrated using microdissection and single cell PCR of Reed-Sternberg and Hodgkin cells (R. Kuppers et al., 1994).
Yu. V. Sidorova, N. V. Ryzhikova, S. Yu. Smirnova, E. E. Nikulina, B. V. Biderman, A. M. Kovrigina, T. N. Moiseeva, N. N. Sharkunov, A. B. Sudarikov   +8 more
doaj   +1 more source

Diffuse large B-cell lymphoma

Dermatology Online Journal, 2012
We present a 56-year-old man with a two-year history of erythematous nodules and plaques on the forehead, frontal aspect of the scalp, and left side of the neck. Histopathologic findings are compatible with a diagnosis of diffuse large B-cell lymphoma (DLBCL).
Mundi, Jyoti P, Leger, Marie, Terushkin, Vitaly, Fischer, Max, Patel, Rishi, Meehan, Shane, Latkowski, Jo-Ann   +6 more
openaire   +4 more sources

Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas [PDF]

, 2007
Integrative genomic and gene-expression analyses have identified amplified oncogenes in B-cell non-Hodgkin lymphoma (B-NHL), but the capability of such technologies to localize tumor suppressor genes within homozygous deletions remains unexplored.
Agirre-Ena, X. (Xabier), Beltran, E. (E.), Climent, J. (J.), Dyer, M.J.S. (Martin J. S.), Fresquet, V. (Vicente), Garcia, J.F. (José Francisco), Karran, E.L. (E. L.), Marin, M. (Miguel), Martinez-Climent, J.A. (José Ángel), Marugan, I. (Isabel), Mestre-Escorihuela, C. (Cinta), Pinkel, D. (Daniel), Prosper, F. (Felipe), Richter, J.A. (José Ángel), Rosenwald, A. (Andreas), Rubio-Moscardo, F. (Fanny), Sanchez, L. (Lydia), Siebert, R. (Reiner), Staudt, L.M. (Louis M.), Sugimoto, K.J. (Kei-Ji), Wheat, L.M. (Luise M.)   +20 more
core  

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.

New England Journal of Medicine, 2002
B. Coiffier, É. Lepage, J. Brière, R. Herbrecht, H. Tilly, R. Bouabdallah, P. Morel, E. Van Den Neste, G. Salles, P. Gaulard, F. Reyes, P. Lederlin, C. Gisselbrecht   +12 more
semanticscholar   +2 more sources

Brexucabtagene autoleucel for mantle cell lymphoma, B-cell precursor acute lymphoblastic leukaemia. [PDF]

Aust Prescr, 2023
europepmc   +1 more source

Axicabtagene Ciloleucel CAR T‐Cell Therapy in Refractory Large B‐Cell Lymphoma

New England Journal of Medicine, 2017
S. Neelapu, F. Locke, N. Bartlett, L. Lekakis, D. Miklos, C. Jacobson, I. Braunschweig, O. Oluwole, T. Siddiqi, Yi Lin, J. Timmerman, P. Stiff, J. Friedberg, I. Flinn, A. Goy, B. Hill, Mitchell R. Smith, A. Deol, U. Farooq, P. Mcsweeney, J. Muñoz, I. Avivi, J. Castro, J. Westin, J. Chavez, A. Ghobadi, K. Komanduri, R. Levy, E. Jacobsen, T. Witzig, P. Reagan, A. Bot, J. Rossi, L. Navale, Yi-zhou Jiang, J. Aycock, M. Elias, David D. Chang, J. Wiezorek, W. Go   +39 more
semanticscholar   +1 more source

Expression of interleukin 2 receptors on activated human B cells. [PDF]

, 1984
Using anti-Tac, a monoclonal anti-interleukin 2 (IL-2) receptor antibody, we have explored the possibility that certain activated B cells display receptors for IL-2.
Bongiovanni, KF, Depper, JM, Goldman, CK, Greene, WC, Korsmeyer, SJ, Leonard, WJ, Robb, RJ, Sharrow, SO, Waldmann, TA   +8 more
core